The organization argues that designating pharmacists as providers under Medicare Part B would have allowed Congress to dramatically expand COVID-19 testing and immunization efforts.
“The final coronavirus stimulus legislation during this election year presents our shining opportunity to achieve a targeted version of provider status. Together with our members, APhA wants to unleash the full potential of pharmacists’ contributions for testing and immunization during COVID-19,” APhA CEO Scott Knoer, PharmD, said.
APhA created a petition urging Congress to include provider status for pharmacists in its next legislative package.
More articles on pharmacy:
Trump’s meeting with pharma execs canceled after drug lobbies refuse to show up
AstraZeneca to pay Emergent $174M to expand production of COVID-19 vaccine candidate
Generic drug trade group loses bid to block California pay-to-delay law
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
